These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1317262)

  • 1. p53 Mutations in human hepatocellular carcinomas from Germany.
    Kress S; Jahn UR; Buchmann A; Bannasch P; Schwarz M
    Cancer Res; 1992 Jun; 52(11):3220-3. PubMed ID: 1317262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.
    Hsu HC; Huang AM; Lai PL; Chien WM; Peng SY; Lin SW
    Hepatology; 1994 Jan; 19(1):122-8. PubMed ID: 7903951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1252-60. PubMed ID: 7868063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation spectrum in hepatocellular carcinoma.
    Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
    Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas.
    Debuire B; Paterlini P; Pontisso P; Basso G; May E
    Oncogene; 1993 Aug; 8(8):2303-6. PubMed ID: 8393166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride.
    Barbin A; Froment O; Boivin S; Marion MJ; Belpoggi F; Maltoni C; Montesano R
    Cancer Res; 1997 May; 57(9):1695-8. PubMed ID: 9135010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
    Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation at codon 249 of p53 gene in a human hepatoblastoma.
    Kar S; Jaffe R; Carr BI
    Hepatology; 1993 Sep; 18(3):566-9. PubMed ID: 8395458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.
    Hayashi H; Sugio K; Matsumata T; Adachi E; Takenaka K; Sugimachi K
    Hepatology; 1995 Dec; 22(6):1702-7. PubMed ID: 7489977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.
    Tada M; Omata M; Ohto M
    Cancer Res; 1990 Feb; 50(4):1121-4. PubMed ID: 2153451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.